NUS End Period Cash Flow from 2010 to 2024

NUS Stock  USD 7.69  0.25  3.36%   
Nu Skin End Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. End Period Cash Flow will likely drop to about 248.8 M in 2024. From the period from 2010 to 2024, Nu Skin End Period Cash Flow quarterly data regression had r-value of  0.1 and coefficient of variation of  32.39. View All Fundamentals
 
End Period Cash Flow  
First Reported
1997-03-31
Previous Quarter
224.2 M
Current Value
227.8 M
Quarterly Volatility
132.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0844 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
  
Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Nu Skin Enterprises over the last few years. It is Nu Skin's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Very volatile
   End Period Cash Flow   
       Timeline  

NUS End Period Cash Flow Regression Statistics

Arithmetic Mean318,480,808
Geometric Mean294,803,843
Coefficient Of Variation32.39
Mean Deviation72,772,471
Median320,025,000
Standard Deviation103,165,653
Sample Variance10643.2T
Range462M
R-Value0.1
Mean Square Error11347.8T
R-Squared0.01
Significance0.72
Slope2,301,103
Total Sum of Squares149004.1T

NUS End Period Cash Flow History

2024248.8 M
2023256.1 M
2022264.7 M
2021339.6 M
2020402.7 M
2019335.6 M
2018386.9 M

About Nu Skin Financial Statements

Nu Skin shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow256.1 M248.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.